Wim J. Riedel

The ketamine model of positive, negative and cognitive symptoms in schizophrenia: facts and frictions
J Psychopharmacol 2007 21: 235-236. [PDF] [References]  

David Nutt

Rob Kerwin — an appreciation
J Psychopharmacol 2007 21: 237. [PDF]  

P.R. Corlett, G.D. Honey, and P.C. Fletcher

From prediction error to psychosis: ketamine as a pharmacological model of delusions
J Psychopharmacol 2007 21: 238-252. [Abstract] [PDF] [References]  

Eugenii A. Rabiner

Imaging of striatal dopamine release elicited with NMDA antagonists: is there anything there to be seen?
J Psychopharmacol 2007 21: 253-258. [Abstract] [PDF] [References]  

Boris A. Chizh

Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways
J Psychopharmacol 2007 21: 259-271. [Abstract] [PDF] [References]  

Christian Gilles and Remy Luthringer

Pharmacological models in healthy volunteers: their use in the clinical development of psychotropic drugs
J Psychopharmacol 2007 21: 272-282. [Abstract] [PDF] [References]  

Charles H. Large

Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?
J Psychopharmacol 2007 21: 283-301. [Abstract] [PDF] [References]  

Jackie Cilia, Paula Hatcher, Charlie Reavill, and Declan N. C. Jones

(±) Ketamine-induced prepulse inhibition deficits of an acoustic startle response in rats are not reversed by antipsychotics
J Psychopharmacol 2007 21: 302-311. [Abstract] [PDF] [References]  

K. Heekeren, A. Neukirch, J. Daumann, M. Stoll, M. Obradovic, K.-A. Kovar, M.A. Geyer, and E. GouzouLis-Mayfrank

Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis
J Psychopharmacol 2007 21: 312-320. [Abstract] [PDF] [References]  

Peter H. Boeijinga, L. Soufflet, F. Santoro, and R. Luthringer

Ketamine effects on CNS responses assessed with MEG/EEG in a passive auditory sensory-gating paradigm: an attempt for modelling some symptoms of psychosis in man
J Psychopharmacol 2007 21: 321-337. [Abstract] [PDF] [References]  

MichaeL A. Covington, Wim J. Riedel, Cati Brown, Congzhou He, Eric Morris, Sara Weinstein, James SempLe, and John Brown

Does ketamine mimic aspects of schizophrenic speech?
J Psychopharmacol 2007 21: 338-346. [Abstract] [PDF] [References]  

Peter J. Uhlhaas, Isobel Millard, Leslie Muetzelfeldt, H. Valerie Curran, and CeLia J.A. Morgan

Perceptual organization in ketamine users: preliminary evidence of deficits on night of drug use but not 3 days later
J Psychopharmacol 2007 21: 347-352. [Abstract] [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.